. 2012 Dec;5(4):192–200. doi: 10.2478/v10102-012-0032-3

Table 6.

Effect of ceftriaxone plus sulbactam with VRP1034 on hematological and δ ALAD parameters in cadmium exposed group after 21 days of treatment.

Group	Hb (g/dL)	RBC (10⁶/µL)	HCT %	WBC (10³/µL)	δ-ALAD in blood (nmol/min/ml erythocyte)
Control	13.93±0.19	7.36±0.10	39.38±0.66	5.12±0.81	9.14±0.71
Cd-exposed	9.27±0.55^***	7.01±0.08^*	36.89±0.43^**	11.25±1.31^***	3.55±0.61^***
Cd+Ceftriaxone plus sulbactam with VRP1034	11.22±0.99^**	7.20±0.06^ns	37.78±0.6^*	7.84±0.58^**	6.74±0.50^***

All data are Mean ± SD of each group. Newman-Keuls test was performed for statistical significance between control group vs Cd exposed group and Cd exposed group vs ceftriaxone plus sulbactam with VRP1034 treated group.

^***

Where p<0.001 (highly significant)

^**

p<0.01(significant)

p<0.05 (significant)

^Ns

p>0.05 (non significant).